These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


431 related items for PubMed ID: 23401096

  • 1. Essential role of stem cell factor-c-Kit signalling pathway in bleomycin-induced pulmonary fibrosis.
    Ding L, Dolgachev V, Wu Z, Liu T, Nakashima T, Wu Z, Ullenbruch M, Lukacs NW, Chen Z, Phan SH.
    J Pathol; 2013 Jun; 230(2):205-14. PubMed ID: 23401096
    [Abstract] [Full Text] [Related]

  • 2. Characterization of lung stem cell niches in a mouse model of bleomycin-induced fibrosis.
    Banerjee ER, Henderson WR.
    Stem Cell Res Ther; 2012 May 29; 3(3):21. PubMed ID: 22643035
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of the stem cell factor 248 isoform attenuates the development of pulmonary remodeling disease.
    Rasky A, Habiel DM, Morris S, Schaller M, Moore BB, Phan S, Kunkel SL, Phillips M, Hogaboam C, Lukacs NW.
    Am J Physiol Lung Cell Mol Physiol; 2020 Jan 01; 318(1):L200-L211. PubMed ID: 31747308
    [Abstract] [Full Text] [Related]

  • 4. TGFβ signaling in lung epithelium regulates bleomycin-induced alveolar injury and fibroblast recruitment.
    Degryse AL, Tanjore H, Xu XC, Polosukhin VV, Jones BR, Boomershine CS, Ortiz C, Sherrill TP, McMahon FB, Gleaves LA, Blackwell TS, Lawson WE.
    Am J Physiol Lung Cell Mol Physiol; 2011 Jun 01; 300(6):L887-97. PubMed ID: 21441353
    [Abstract] [Full Text] [Related]

  • 5. Role of the SDF-1/CXCR4 axis in the pathogenesis of lung injury and fibrosis.
    Xu J, Mora A, Shim H, Stecenko A, Brigham KL, Rojas M.
    Am J Respir Cell Mol Biol; 2007 Sep 01; 37(3):291-9. PubMed ID: 17463394
    [Abstract] [Full Text] [Related]

  • 6. Role of stem cell factor and bone marrow-derived fibroblasts in airway remodeling.
    Dolgachev VA, Ullenbruch MR, Lukacs NW, Phan SH.
    Am J Pathol; 2009 Feb 01; 174(2):390-400. PubMed ID: 19147822
    [Abstract] [Full Text] [Related]

  • 7. [Effects of antisense oligonucleotide to nuclear factor-kappaB on the development of bleomycin-induced pulmonary fibrosis and IL-4 expression therein: experiment with mice].
    Zhang XY, Zhou Y, Liu WQ, Zhao L, Li SQ.
    Zhonghua Yi Xue Za Zhi; 2007 Jan 16; 87(3):195-9. PubMed ID: 17425852
    [Abstract] [Full Text] [Related]

  • 8. [Effects of andrographolide on the concentration of cytokines in BALF and the expressions of type I and III collagen mRNA in lung tissue in bleomycin-induced rat pulmonary fibrosis].
    Zhu HL, Huang CL, Wang WJ, Zhan XQ, Fan XM.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jul 16; 27(7):725-9. PubMed ID: 21722520
    [Abstract] [Full Text] [Related]

  • 9. Megakaryoblastic leukemia-1 is required for the development of bleomycin-induced pulmonary fibrosis.
    Bernau K, Ngam C, Torr EE, Acton B, Kach J, Dulin NO, Sandbo N.
    Respir Res; 2015 Mar 27; 16(1):45. PubMed ID: 25885656
    [Abstract] [Full Text] [Related]

  • 10. Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse.
    Yasui H, Gabazza EC, Tamaki S, Kobayashi T, Hataji O, Yuda H, Shimizu S, Suzuki K, Adachi Y, Taguchi O.
    Am J Respir Crit Care Med; 2001 Jun 27; 163(7):1660-8. PubMed ID: 11401891
    [Abstract] [Full Text] [Related]

  • 11. Fibroblast growth factor 2 decreases bleomycin-induced pulmonary fibrosis and inhibits fibroblast collagen production and myofibroblast differentiation.
    Koo HY, El-Baz LM, House S, Cilvik SN, Dorry SJ, Shoukry NM, Salem ML, Hafez HS, Dulin NO, Ornitz DM, Guzy RD.
    J Pathol; 2018 Sep 27; 246(1):54-66. PubMed ID: 29873400
    [Abstract] [Full Text] [Related]

  • 12. Hypoxia-preconditioned mesenchymal stem cells attenuate bleomycin-induced pulmonary fibrosis.
    Lan YW, Choo KB, Chen CM, Hung TH, Chen YB, Hsieh CH, Kuo HP, Chong KY.
    Stem Cell Res Ther; 2015 May 20; 6(1):97. PubMed ID: 25986930
    [Abstract] [Full Text] [Related]

  • 13. Asiatic acid ameliorates pulmonary fibrosis induced by bleomycin (BLM) via suppressing pro-fibrotic and inflammatory signaling pathways.
    Dong SH, Liu YW, Wei F, Tan HZ, Han ZD.
    Biomed Pharmacother; 2017 May 20; 89():1297-1309. PubMed ID: 28320097
    [Abstract] [Full Text] [Related]

  • 14. The role of high mobility group box1 in pulmonary fibrosis.
    Hamada N, Maeyama T, Kawaguchi T, Yoshimi M, Fukumoto J, Yamada M, Yamada S, Kuwano K, Nakanishi Y.
    Am J Respir Cell Mol Biol; 2008 Oct 20; 39(4):440-7. PubMed ID: 18441281
    [Abstract] [Full Text] [Related]

  • 15. Mast cells and fibroblasts work in concert to aggravate pulmonary fibrosis: role of transmembrane SCF and the PAR-2/PKC-α/Raf-1/p44/42 signaling pathway.
    Wygrecka M, Dahal BK, Kosanovic D, Petersen F, Taborski B, von Gerlach S, Didiasova M, Zakrzewicz D, Preissner KT, Schermuly RT, Markart P.
    Am J Pathol; 2013 Jun 20; 182(6):2094-108. PubMed ID: 23562441
    [Abstract] [Full Text] [Related]

  • 16. Blockade of platelet-derived growth factor receptor-β, not receptor-α ameliorates bleomycin-induced pulmonary fibrosis in mice.
    Kishi M, Aono Y, Sato S, Koyama K, Azuma M, Abe S, Kawano H, Kishi J, Toyoda Y, Okazaki H, Ogawa H, Uehara H, Nishioka Y.
    PLoS One; 2018 Jun 20; 13(12):e0209786. PubMed ID: 30596712
    [Abstract] [Full Text] [Related]

  • 17. Surfactant protein-D regulates effector cell function and fibrotic lung remodeling in response to bleomycin injury.
    Aono Y, Ledford JG, Mukherjee S, Ogawa H, Nishioka Y, Sone S, Beers MF, Noble PW, Wright JR.
    Am J Respir Crit Care Med; 2012 Mar 01; 185(5):525-36. PubMed ID: 22198976
    [Abstract] [Full Text] [Related]

  • 18. Secretoglobin 3A2 Exhibits Anti-Fibrotic Activity in Bleomycin-Induced Pulmonary Fibrosis Model Mice.
    Cai Y, Kimura S.
    PLoS One; 2015 Mar 01; 10(11):e0142497. PubMed ID: 26559674
    [Abstract] [Full Text] [Related]

  • 19. Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen.
    Ponticos M, Holmes AM, Shi-wen X, Leoni P, Khan K, Rajkumar VS, Hoyles RK, Bou-Gharios G, Black CM, Denton CP, Abraham DJ, Leask A, Lindahl GE.
    Arthritis Rheum; 2009 Jul 01; 60(7):2142-55. PubMed ID: 19565505
    [Abstract] [Full Text] [Related]

  • 20. Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy.
    Kurita Y, Araya J, Minagawa S, Hara H, Ichikawa A, Saito N, Kadota T, Tsubouchi K, Sato N, Yoshida M, Kobayashi K, Ito S, Fujita Y, Utsumi H, Yanagisawa H, Hashimoto M, Wakui H, Yoshii Y, Ishikawa T, Numata T, Kaneko Y, Asano H, Yamashita M, Odaka M, Morikawa T, Nakayama K, Kuwano K.
    Respir Res; 2017 Jun 02; 18(1):114. PubMed ID: 28577568
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.